FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093508715> ?p ?o ?g. }

• W3093508715 endingPage "131" @default.
• W3093508715 startingPage "120" @default.
• W3093508715 abstract "Asthma is an airway inflammatory disease and a major health problem worldwide. Anti-inflammatory steroids and bronchodilators are the gold-standard therapy for asthma. However, they do not prevent the development of the disease, and critically, a subset of asthmatics are resistant to steroid therapy.To elucidate the therapeutic potential of human β-defensins (hBD), such as hBD2 mild to moderate and severe asthma.We investigated the role of hBD2 in a steroid-sensitive, house dust mite-induced allergic airways disease (AAD) model and a steroid-insensitive model combining ovalbumin-induced AAD with C muridarum (Cmu) respiratory infection.In both models, we demonstrated that therapeutic intranasal application of hBD2 significantly reduced the influx of inflammatory cells into the bronchoalveolar lavage fluid. Furthermore, key type 2 asthma-related cytokines IL-9 and IL-13, as well as additional immunomodulating cytokines, were significantly decreased after administration of hBD2 in the steroid-sensitive model. The suppression of inflammation was associated with improvements in airway physiology and treatment also suppressed airway hyper-responsiveness (AHR) in terms of airway resistance and compliance to methacholine challenge.These data indicate that hBD2 reduces the hallmark features and has potential as a new therapeutic agent in allergic and especially steroid-resistant asthma." @default.
• W3093508715 created "2020-10-29" @default.
• W3093508715 creator A5000386681 @default.
• W3093508715 creator A5002908088 @default.
• W3093508715 creator A5009041563 @default.
• W3093508715 creator A5015543605 @default.
• W3093508715 creator A5031478533 @default.
• W3093508715 creator A5048172674 @default.
• W3093508715 creator A5048476786 @default.
• W3093508715 creator A5053737565 @default.
• W3093508715 creator A5056667390 @default.
• W3093508715 creator A5056732175 @default.
• W3093508715 creator A5057656225 @default.
• W3093508715 creator A5080773158 @default.
• W3093508715 creator A5089963704 @default.
• W3093508715 creator A5090230661 @default.
• W3093508715 date "2020-11-11" @default.
• W3093508715 modified "2023-10-01" @default.
• W3093508715 title "Human β‐defensin‐2 suppresses key features of asthma in murine models of allergic airways disease" @default.
• W3093508715 cites W126340564 @default.
• W3093508715 cites W1579720523 @default.
• W3093508715 cites W1586150156 @default.
• W3093508715 cites W1787801518 @default.
• W3093508715 cites W1983439460 @default.
• W3093508715 cites W1988186731 @default.
• W3093508715 cites W1988964423 @default.
• W3093508715 cites W1990687490 @default.
• W3093508715 cites W1994778879 @default.
• W3093508715 cites W1997152791 @default.
• W3093508715 cites W2002980923 @default.
• W3093508715 cites W2011807378 @default.
• W3093508715 cites W2016878634 @default.
• W3093508715 cites W2022928437 @default.
• W3093508715 cites W2025482750 @default.
• W3093508715 cites W2030041616 @default.
• W3093508715 cites W2035481305 @default.
• W3093508715 cites W2044782575 @default.
• W3093508715 cites W2045898149 @default.
• W3093508715 cites W2049682225 @default.
• W3093508715 cites W2053208368 @default.
• W3093508715 cites W2054602599 @default.
• W3093508715 cites W2055685990 @default.
• W3093508715 cites W2066549796 @default.
• W3093508715 cites W2067171867 @default.
• W3093508715 cites W2082242655 @default.
• W3093508715 cites W2082848636 @default.
• W3093508715 cites W2083845392 @default.
• W3093508715 cites W2088764647 @default.
• W3093508715 cites W2092190921 @default.
• W3093508715 cites W2094294562 @default.
• W3093508715 cites W2099138589 @default.
• W3093508715 cites W2103585613 @default.
• W3093508715 cites W2104159258 @default.
• W3093508715 cites W2105575479 @default.
• W3093508715 cites W2106315342 @default.
• W3093508715 cites W2112970562 @default.
• W3093508715 cites W2115289014 @default.
• W3093508715 cites W2126515688 @default.
• W3093508715 cites W2134373232 @default.
• W3093508715 cites W2136199835 @default.
• W3093508715 cites W2137175341 @default.
• W3093508715 cites W2140731876 @default.
• W3093508715 cites W2141475970 @default.
• W3093508715 cites W2141611143 @default.
• W3093508715 cites W2142181216 @default.
• W3093508715 cites W2142321394 @default.
• W3093508715 cites W2144712546 @default.
• W3093508715 cites W2146036781 @default.
• W3093508715 cites W2155897738 @default.
• W3093508715 cites W2156522249 @default.
• W3093508715 cites W2158364865 @default.
• W3093508715 cites W2160747323 @default.
• W3093508715 cites W2161593731 @default.
• W3093508715 cites W2161677751 @default.
• W3093508715 cites W2167362045 @default.
• W3093508715 cites W2328990695 @default.
• W3093508715 cites W2412707497 @default.
• W3093508715 cites W2439973029 @default.
• W3093508715 cites W2528396364 @default.
• W3093508715 cites W2576327811 @default.
• W3093508715 cites W2586238008 @default.
• W3093508715 cites W2592960610 @default.
• W3093508715 cites W2593240146 @default.
• W3093508715 cites W2604137520 @default.
• W3093508715 cites W2609943333 @default.
• W3093508715 cites W2620388110 @default.
• W3093508715 cites W2729811919 @default.
• W3093508715 cites W2755605199 @default.
• W3093508715 cites W2757378082 @default.
• W3093508715 cites W2782031276 @default.
• W3093508715 cites W2936073877 @default.
• W3093508715 cites W3003813833 @default.
• W3093508715 cites W4292198229 @default.
• W3093508715 doi "https://doi.org/10.1111/cea.13766" @default.
• W3093508715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33098152" @default.
• W3093508715 hasPublicationYear "2020" @default.
• W3093508715 type Work @default.
• W3093508715 sameAs 3093508715 @default.

• next